Flexeril (cyclobenzaprine) and Adderall have opposing sedating and stimulating effects. Learn the specific interaction considerations.
Jump to a section
Cyclobenzaprine (Flexeril), a muscle relaxant, and Adderall have directly opposing effects on the central nervous system, and cyclobenzaprine specifically carries a serotonergic component that adds another layer of interaction consideration beyond the general sedation-versus-stimulation concern.
Key Takeaways on Cyclobenzaprine and Adderall
- Cyclobenzaprine is chemically related to tricyclic antidepressants, adding a serotonergic dimension to its interaction profile with Adderall.
- The combination can mask sedation similar to other stimulant-depressant combinations.
- Both medications can independently affect heart rate, adding a cardiovascular consideration.
- This combination should be managed by a prescriber aware of both medications.
How Cyclobenzaprine Works
Cyclobenzaprine relieves muscle spasms by acting on the central nervous system rather than directly on muscle tissue. Structurally, it's related to tricyclic antidepressants, which is relevant because it carries some serotonergic activity — a detail that adds nuance beyond the simple "sedating vs. stimulating" framing.
Why the Combination Needs Extra Attention
Opposing sedation and stimulation
Similar to other stimulant-depressant combinations, cyclobenzaprine's sedation can be masked by Adderall's alertness, making self-assessment of impairment unreliable — a particular concern for activities like driving.
Serotonergic considerations
Cyclobenzaprine's tricyclic-related structure means it carries some serotonergic activity, which is relevant if Adderall is combined with other serotonergic medications too (like certain antidepressants) — the more serotonergic medications in the mix, the more this becomes a genuine monitoring consideration.
Cardiovascular effects
Both medications can independently affect heart rate, which is worth monitoring particularly for anyone with existing cardiovascular risk factors.
What to Watch For
- Unexpected drowsiness or dizziness — despite Adderall's stimulant effect.
- Signs of serotonin excess — agitation, rapid heartbeat, muscle twitching — particularly if other serotonergic medications are also involved.
- Impaired coordination — that doesn't match how alert you feel.
- Changes in heart rate or blood pressure — worth reporting rather than assuming is expected.
Staying Safe on Both Medications
- Confirm both prescriptions with the same provider or pharmacist — so the interaction is being actively monitored.
- Disclose all other medications — especially other serotonergic drugs, given cyclobenzaprine's related activity.
- Avoid driving until you understand how the combination affects you — the masking effect makes self-assessment unreliable.
- Report unusual symptoms promptly — rather than assuming they're just how the medications feel together.
Getting Coordinated Care
If you're managing a musculoskeletal condition alongside ADHD, coordinated prescriber oversight is what makes combining these medications safe. Lantana Recovery's Adderall resources are also available if stimulant use has become harder to manage as prescribed. Our guides on beta blockers and Adderall and Prozac and Adderall's serotonin syndrome risk cover other combination questions.
FAQ: Cyclobenzaprine and Adderall
Is it common to be prescribed both together?
Why does cyclobenzaprine's chemical structure matter for this interaction?
Should I avoid driving on this combination?
Bottom Line
Cyclobenzaprine and Adderall have opposing central nervous system effects, plus a serotonergic consideration from cyclobenzaprine's chemical structure. Coordinated prescriber oversight, careful monitoring, and caution around activities like driving make this combination manageable.

Sources
- DailyMed (NIH) — Cyclobenzaprine (Flexeril) prescribing informationhttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c5c7c1b-6e1e-4b6e-9c1e-8f0c9b0c6c1b
- DailyMed (NIH) — Adderall prescribing informationhttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f3c8c65-4a51-46e6-9908-2e60a0c33e59

Reviewed by
Warren PhillipsCo-Founder, LMSW · Editorial Reviewer
Warren Phillips is a Co-Founder of Lantana Recovery and a Licensed Master Social Worker (LMSW) specializing in substance abuse and mental health treatment. He previously worked in various capacities at Turnbridge Addiction Treatment and Clearpoint Recovery Center before co-founding Lantana Recovery. Warren's clinical approach draws on a strengths-based perspective, Twelve Step philosophies, Cognitive Behavioral Therapy, and Motivational Interviewing. He brings both personal and professional experience to his work — as a person in long-term recovery from alcohol and illicit substances, he has used that experience to help shape Lantana's treatment programming. Warren grew up in Memphis, TN and St. Louis, MO, attended college in Mississippi, and lived in California and Connecticut before relocating to Charleston. He now lives in Mount Pleasant with his wife, Angela, and their two young children, Hall and Sam.
Written by the Lantana Recovery Editorial Team and reviewed for clinical accuracy before publication.




